Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers

Status unconfirmed · Phase 1

Conditions studied: Alzheimer Disease, Dementia

In brief

This project is developing a novel disease-modifying compound for Alzheimer's disease (AD).

Key facts

Study ID
NCT05817643
Run by
Allyx Therapeutics
People needed
12
Starts
2023-01-10
Expected to finish
2024-11-15
Last updated by the study team
2024-07-30

Who can join

Age: 50 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.